These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33459791)

  • 21. Risk scoring for the primary prevention of cardiovascular disease.
    Karmali KN; Persell SD; Perel P; Lloyd-Jones DM; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006887. PubMed ID: 28290160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of BMI with cardiovascular disease incidence and mortality in patients with type 2 diabetes mellitus: A systematic review and dose-response meta-analysis of cohort studies.
    Zhao Y; Qie R; Han M; Huang S; Wu X; Zhang Y; Feng Y; Yang X; Li Y; Wu Y; Liu D; Hu F; Zhang M; Sun L; Hu D
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):1976-1984. PubMed ID: 33965298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium levels and the risk of all-cause and cardiovascular mortality among patients with cardiovascular diseases: a meta-analysis of cohort studies.
    Fan Y; Wu M; Li X; Zhao J; Shi J; Ding L; Jiang H; Li Z; Zhang W; Ma T; Wang D; Ma L
    Nutr J; 2024 Jan; 23(1):8. PubMed ID: 38195532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
    JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of characteristics of pharmacotherapy on non-adherence in chronic cardiovascular disease: A systematic review and meta-analysis of observational studies.
    Schneider APH; Gaedke MÂ; Garcez A; Barcellos NT; Paniz VMV
    Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29193650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the Drivers of Racial/Ethnic Disparities in Non-Adherence to Antihypertensive Medications and Mortality Due to Heart Disease and Stroke: A County-Level Analysis.
    Donneyong MM; Fischer MA; Langston MA; Joseph JJ; Juarez PD; Zhang P; Kline DM
    Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886429
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.
    Shin S; Song H; Oh SK; Choi KE; Kim H; Jang S
    Hypertens Res; 2013 Nov; 36(11):1000-5. PubMed ID: 23966057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of antihypertensive medication and high-intensity interval training in hypertensive metabolic syndrome individuals.
    Ramirez-Jimenez M; Morales-Palomo F; Moreno-Cabañas A; Alvarez-Jimenez L; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2021 Jul; 31(7):1411-1419. PubMed ID: 33662166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Cycling with Risk of All-Cause and Cardiovascular Disease Mortality: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies.
    Zhao Y; Hu F; Feng Y; Yang X; Li Y; Guo C; Li Q; Tian G; Qie R; Han M; Huang S; Wu X; Zhang Y; Wu Y; Liu D; Zhang D; Cheng C; Zhang M; Yang Y; Shi X; Lu J; Hu D
    Sports Med; 2021 Jul; 51(7):1439-1448. PubMed ID: 33774807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.
    Wu PH; Yang CY; Yao ZL; Lin WZ; Wu LW; Chang CC
    Am J Hypertens; 2010 Feb; 23(2):155-60. PubMed ID: 19927135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-Response Association of Low and Normal Ankle Brachial Index With the Risk of Cardiovascular Disease Morbidity and Mortality.
    Zhang J; Sun H; Yang X; Feng Y; Li Y; Han M; Qie R; Huang S; Yuan L; Li T; Hu H; Li X; Liu D; Wu X; Zhang Y; Wu Y; Hu F; Zhang M; Sun L; Zhao Y; Hu D
    Angiology; 2023 Aug; 74(7):640-648. PubMed ID: 35830466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age at menarche and risk of all-cause and cardiovascular mortality: a systematic review and dose-response meta-analysis.
    Chen X; Liu Y; Sun X; Yin Z; Li H; Liu X; Zhang D; Cheng C; Liu L; Liu F; Zhou Q; Wang C; Li L; Wang B; Zhao Y; Liu D; Zhang M; Hu D
    Menopause; 2018 Dec; 26(6):670-676. PubMed ID: 30562317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to antihypertensive medications and associated factors among hypertensive patients in Ethiopia: Systematic review and meta-analysis.
    Tola Gemeda A; Regassa LD; Weldesenbet AB; Merga BT; Legesse N; Tusa BS
    SAGE Open Med; 2020; 8():2050312120982459. PubMed ID: 33489230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes and cardiovascular events in hypertensive patients.
    Alderman MH; Cohen H; Madhavan S
    Hypertension; 1999 May; 33(5):1130-4. PubMed ID: 10334799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobile Apps to Improve Medication Adherence in Cardiovascular Disease: Systematic Review and Meta-analysis.
    Al-Arkee S; Mason J; Lane DA; Fabritz L; Chua W; Haque MS; Jalal Z
    J Med Internet Res; 2021 May; 23(5):e24190. PubMed ID: 34032583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
    Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention.
    Martin-Ruiz E; Olry-de-Labry-Lima A; Ocaña-Riola R; Epstein D
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):200-215. PubMed ID: 29343082
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.